Amazon To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday

- JP Morgan raised **Argan Inc** (NYSE: AGX) price target from $315 to $370. JP Morgan analyst Michael Fairbanks downgraded the stock from Overweight to Neutral. Argan shares closed at $395.20 on Friday. See how other analysts view this stock.
- Oppenheimer raised the price target for **Amazon.com Inc** (NASDAQ: AMZN) from $290 to $305. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Amazon shares closed at $233.22 on Friday. See how other analysts view this stock.
- RBC Capital raised **PTC Therapeutics, Inc.** (NASDAQ: PTCT) price target from $82 to $91. RBC Capital analyst Brian Abrahams downgraded the stock from Outperform to Sector Perform. PTC Therapeutics shares closed at $85.99 on Friday. See how other analysts view this stock.
- Barclays lowered the price target for **Crown Castle Inc** (NYSE: CCI) from $104 to $101. Barclays analyst Brendan Lynch downgraded the stock from Overweight to Equal-Weight. Crown Castle shares closed at $91.28 on Friday. See how other analysts view this stock.
- Benchmark boosted the price target for **Light & Wonder, Inc**. (NASDAQ: LNW) from $90 to $110. Benchmark analyst Mike Hickey maintained a Buy rating. Light & Wonder shares closed at $86.22 on Friday. See how other analysts view this stock.
- Mizuho increased **Insmed Incorporated** (NASDAQ: INSM) price target from $196 to $256. Mizuho analyst Graig Suvannavejh maintained an Outperform rating. Insmed shares settled at $207.77 on Friday. See how other analysts view this stock.
- Argus Research cut **Target Corporation** (NYSE: TGT) price target from $135 to $125. Argus Research analyst Christopher Graja maintained a Buy rating. Target shares closed at $90.62 on Friday. See how other analysts view this stock.
- Citizens increased **Prothena Corporation plc** (NASDAQ: PRTA) price target from $11 to $19. Citizens analyst Jason Butler maintained a Market Outperform rating. Prothena shares closed at $10.75 on Friday.  See how other analysts view this stock.
- HSBC raised the price target for **Thermo Fisher Scientific Inc**. (NYSE: TMO) from $550 to $670. HSBC analyst Sidharth Sahoo upgraded the stock from Hold to Buy. Thermo Fisher Scientific shares settled at $590.76 on Friday. See how other analysts view this stock.
- BMO Capital cut **Old Dominion Freight Line, Inc.** (NASDAQ: ODFL) price target from $172 to $170. BMO Capital analyst Fadi Chamoun upgraded the stock from Market Perform to Outperform. Old Dominion Freight shares closed at $135.29 on Friday. See how other analysts view this stock.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>



<ul class="wp-block-list">
<li>JP Morgan raised <strong>Argan Inc</strong> <a href="https://www.benzinga.com/quote/AGX" target="_blank" class="ticker-link" data-ticker="AGX" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/AGX">AGX</a>)</a> price target from $315 to $370. JP Morgan analyst Michael Fairbanks downgraded the stock from Overweight to Neutral. Argan shares closed at $395.20 on Friday. <a href="https://www.benzinga.com/quote/AGX/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Oppenheimer raised the price target for <strong>Amazon.com Inc</strong> <a href="https://www.benzinga.com/quote/AMZN" target="_blank" class="ticker-link" data-ticker="AMZN" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/AMZN">AMZN</a>)</a> from $290 to $305. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Amazon shares closed at $233.22 on Friday. <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock.</a></li>



<li>RBC Capital raised <strong>PTC Therapeutics, Inc.</strong> <a href="https://www.benzinga.com/quote/PTCT" target="_blank" class="ticker-link" data-ticker="PTCT" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PTCT">PTCT</a>)</a> price target from $82 to $91. RBC Capital analyst Brian Abrahams downgraded the stock from Outperform to Sector Perform. PTC Therapeutics shares closed at $85.99 on Friday. <a href="https://www.benzinga.com/quote/PTCT/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Barclays lowered the price target for <strong>Crown Castle Inc</strong> <a href="https://www.benzinga.com/quote/CCI" target="_blank" class="ticker-link" data-ticker="CCI" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/CCI">CCI</a>)</a> from $104 to $101. Barclays analyst Brendan Lynch downgraded the stock from Overweight to Equal-Weight. Crown Castle shares closed at $91.28 on Friday. <a href="https://www.benzinga.com/quote/CCI/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Benchmark boosted the price target for <strong>Light &amp; Wonder, Inc</strong>. <a href="https://www.benzinga.com/quote/LNW" target="_blank" class="ticker-link" data-ticker="LNW" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/LNW">LNW</a>)</a> from $90 to $110. Benchmark analyst Mike Hickey maintained a Buy rating. Light &amp; Wonder shares closed at $86.22 on Friday. <a href="https://www.benzinga.com/quote/LNW/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Mizuho increased<strong> Insmed Incorporated</strong> <a href="https://www.benzinga.com/quote/INSM" target="_blank" class="ticker-link" data-ticker="INSM" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/INSM">INSM</a>)</a> price target from $196 to $256. Mizuho analyst Graig Suvannavejh maintained an Outperform rating. Insmed shares settled at $207.77 on Friday. <a href="https://www.benzinga.com/quote/INSM/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Argus Research cut <strong>Target Corporation</strong> <a href="https://www.benzinga.com/quote/TGT" target="_blank" class="ticker-link" data-ticker="TGT" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/TGT">TGT</a>)</a> price target from $135 to $125. Argus Research analyst Christopher Graja maintained a Buy rating. Target shares closed at $90.62 on Friday. <a href="https://www.benzinga.com/quote/TGT/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Citizens increased<strong> Prothena Corporation plc</strong> <a href="https://www.benzinga.com/quote/PRTA" target="_blank" class="ticker-link" data-ticker="PRTA" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PRTA">PRTA</a>)</a> price target from $11 to $19. Citizens analyst Jason Butler maintained a Market Outperform rating. Prothena shares closed at $10.75 on Friday.  <a href="https://www.benzinga.com/quote/PRTA/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>HSBC raised the price target for <strong>Thermo Fisher Scientific Inc</strong>. <a href="https://www.benzinga.com/quote/TMO" target="_blank" class="ticker-link" data-ticker="TMO" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/TMO">TMO</a>)</a> from $550 to $670. HSBC analyst Sidharth Sahoo upgraded the stock from Hold to Buy. Thermo Fisher Scientific shares settled at $590.76 on Friday. <a href="https://www.benzinga.com/quote/TMO/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>BMO Capital cut <strong>Old Dominion Freight Line, Inc.</strong> <a href="https://www.benzinga.com/quote/ODFL" target="_blank" class="ticker-link" data-ticker="ODFL" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ODFL">ODFL</a>)</a> price target from $172 to $170. BMO Capital analyst Fadi Chamoun upgraded the stock from Market Perform to Outperform. Old Dominion Freight shares closed at $135.29 on Friday. <a href="https://www.benzinga.com/quote/ODFL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>



<p>Considering buying AMZN stock? Here&#8217;s what analysts think:</p>



<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/AMZN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="591" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01094115/image-18-1024x591.png" alt="" class="wp-image-1190849" style="width:573px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01094115/image-18-1024x591.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01094115/image-18-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01094115/image-18-768x443.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01094115/image-18.png 1138w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>



<p><strong>Read This Next:</strong></p>



<ul class="wp-block-list">
<li><strong> <a href="https://www.benzinga.com/trading-ideas/dividends/25/11/49113168/wall-streets-most-accurate-analysts-weigh-in-on-3-financial-stocks-with-over-13-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 13% Dividend Yields</a></strong></li>
</ul>



<p>Photo via Shutterstock</p>